Model-Informed Drug Development in the Age of AI
Lorem ipsum dolor sit amet consectetur. Donec diam risus volutpat tempor. Massa accumsan aliquam nibh…
CertaraMarch 10, 2025
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
March 5, 2025 McKemey joins Certara to accelerate growth of its strategic drug development solutions …
CertaraMarch 5, 2025
Postmarketing Assessment of Antibody–Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach
This study explores a model-based meta-analysis (MBMA) and a clinical utility index (CUI) approach to…
CertaraMarch 4, 2025
Machine Learning for PK/PD Modeling in Drug Development
Pharmacometricians can use machine learning for PK/PD modeling to help them characterize the safety and…
CertaraMarch 4, 2025
